摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-quinazoline | 52903-22-7

中文名称
——
中文别名
——
英文名称
2-chloro-4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-quinazoline
英文别名
2-chloro-6,7-dimethoxy-4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)quinazoline;2-chloro-4-(1,2,3,4-tetrahydro-6,7-dimethoxyisoquinol-2yl)-6,7-dimethoxyquinazoline;2-chloro-4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxyquinazoline
2-chloro-4-(6,7-dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-6,7-dimethoxy-quinazoline化学式
CAS
52903-22-7
化学式
C21H22ClN3O4
mdl
——
分子量
415.876
InChiKey
CYZSIZPWTTTXNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    560.6±50.0 °C(Predicted)
  • 密度:
    1.299±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    65.9
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Aminoquinazoline therapeutic agents
    申请人:Pfizer Inc.
    公开号:US04044136A1
    公开(公告)日:1977-08-23
    A series of novel 2-amino and 4-aminoquinazoline derivatives have been prepared, including their acid addition salts. These derivatives all possess a single nitrogen-containing benzo-fused heterocyclic ring moiety at either the 4- or 2-positions of the molecule, respectively, with the ring moiety being attached through the nitrogen atom to the aforesaid quinazoline nucleus. Such compounds are useful in therapy as highly potent antihypertensive agents. Methods for their preparation are described in detail, including various synthetic routes leading to the required novel intermediates.
    一系列新型的2-氨基和4-氨基喹唑啉衍生物已经制备出来,包括它们的酸加成盐。这些衍生物在分子的4-或2-位置上都具有单一的含氮苯并杂环环基,该环基通过氮原子与上述喹唑啉核结构连接。这些化合物作为高效的降压剂在治疗中有用。详细描述了它们的制备方法,包括导致所需新型中间体的各种合成途径。
  • [EN] QUINAZOLINES DERIVATIVES FOR ENHANCING ANTITUMOR ACTIVITY
    申请人:PFIZER INC.
    公开号:WO1992007844A1
    公开(公告)日:1992-05-14
    (EN) 2,4-Diaminoquinazoline derivatives as potentiators of chemotherapeutic agents in the treatment of cancer.(FR) Dérivés de 2,4-diaminoquinazoline utiles en tant que potentialisateurs des agents chimiothérapiques utilisés dans le traitement de cancer.
    2,4-吡咯二胺衍生物作为化疗药物增强剂,在癌症治疗中的应用。
  • QUINAZOLINES DERIVATIVES FOR ENHANCING ANTITUMOR ACTIVITY
    申请人:PFIZER INC.
    公开号:EP0556310A1
    公开(公告)日:1993-08-25
  • US5444062A
    申请人:——
    公开号:US5444062A
    公开(公告)日:1995-08-22
  • 2 (OR 4) Amino 4 (or 2) N-hetero quinazolines
    申请人:Pfizer Inc.
    公开号:US03960861A1
    公开(公告)日:1976-06-01
    A series of novel 2-amino and 4-aminoquinazoline derivatives have been prepared, including their acid addition salts. These derivatives all possess a single nitrogen-containing benzo-fused heterocyclic ring moiety at either the 4- or 2- positions of the molecule, respectively, with the ring moiety being attached through the nitrogen atom to the aforesaid quinazoline nucleus. Such compounds are useful in therapy as highly potent antihypertensive agents. Methods for their preparation are described in detail, including various synthetic routes leading to the required novel intermediates.
    已制备一系列新颖的2-氨基和4-氨基喹唑啉衍生物,包括它们的酸加成盐。这些衍生物都在分子的4-或2-位置具有一个含氮苯融合杂环环基,该环基通过氮原子连接到上述喹唑啉核。这些化合物在治疗中具有高效的降压剂作用。详细描述了它们的制备方法,包括通往所需新颖中间体的各种合成途径。
查看更多